{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:44:10Z","timestamp":1785908650140,"version":"3.56.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify independent predictors of diabetic cardiac autonomic neuropathy (DCAN) deterioration in patients with type 2 diabetes mellitus (T2DM), develop machine learning (ML)-based risk prediction models, and explore the underlying mediation of glycemic burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective cohort study included 293 T2DM patients who underwent standardized Ewing testing at baseline and follow-up. Univariable and multivariable logistic regression were utilized to identify predictors. Restricted cubic splines (RCS) were applied to evaluate non-linear relationships. Nine ML algorithms were developed and evaluated using AUC and calibration metrics, with SHAP values illustrating feature importance. Mediation analysis was performed to investigate whether longitudinal biomarker changes accounted for the association between HbA1c and DCAN deterioration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During follow-up, 80 patients (27.3%) experienced DCAN deterioration. Multivariable logistic regression identified elevated HbA1c at baseline as an independent risk factor, while SGLT2 inhibitor use was significantly associated with a lower risk of deterioration. RCS analysis revealed a continuous linear risk increase for HbA1c at baseline, whereas the platelet-to-lymphocyte ratio (PLR) at baseline exhibited an inverted U-shaped relationship. Among the ML algorithms, KNN achieved the highest AUC among models meeting the prespecified calibration criterion (AUC\u00a0=\u00a00.913; Brier score = 0.084; calibration slope = 0.701; calibration intercept = \u22120.053). SHAP analysis confirmed SGLT2 inhibitor use, HbA1c, and PLR as the top three predictors. Mediation analysis demonstrated that longitudinal increases in uric acid (\u0394UA) and white blood cell count (\u0394WBC) accounted for 20.6% and 12.9% of the association between HbA1c and DCAN progression, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SGLT2 inhibitor use is significantly associated with a lower risk of DCAN deterioration in T2DM patients, whereas elevated HbA1c levels correlate with disease progression, potentially involving pathways of exacerbated uric acid metabolism and systemic inflammation. Furthermore, the KNN-based ML model serves as a promising proof-of-concept tool for clinical risk stratification that warrants future external validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1901683","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:47:18Z","timestamp":1785905238000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["SGLT2 inhibition, uric acid and inflammation in glycemic burden-related progression of cardiac autonomic neuropathy in type 2 diabetes mellitus: insights from machine learning and mediation analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Jing Jing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Hefei Hospital Affiliated to Anhui Medical University, The Second People\u2019s Hospital of Hefei","place":["Hefei, Anhui, China"]},{"name":"The Fifth Clinical Medical College of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Xiamen University","place":["Xiamen, China"]},{"name":"Department of Neuroscience, The First Affiliated Hospital of Xiamen University","place":["Xiamen, China"]},{"name":"School of Medicine, Xiamen University","place":["Xiamen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hefei Hospital Affiliated to Anhui Medical University, The Second People\u2019s Hospital of Hefei","place":["Hefei, Anhui, China"]},{"name":"The Fifth Clinical Medical College of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hefei Hospital Affiliated to Anhui Medical University, The Second People\u2019s Hospital of Hefei","place":["Hefei, Anhui, China"]},{"name":"The Fifth Clinical Medical College of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan Pan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hefei Hospital Affiliated to Anhui Medical University, The Second People\u2019s Hospital of Hefei","place":["Hefei, Anhui, China"]},{"name":"The Fifth Clinical Medical College of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hefei Hospital Affiliated to Anhui Medical University, The Second People\u2019s Hospital of Hefei","place":["Hefei, Anhui, China"]},{"name":"The Fifth Clinical Medical College of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Hong","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hefei Hospital Affiliated to Anhui Medical University, The Second People\u2019s Hospital of Hefei","place":["Hefei, Anhui, China"]},{"name":"The Fifth Clinical Medical College of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000210","article-title":"Estimating life years lost to diabetes: outcomes from analysis of national diabetes audit and office of national statistics data","volume":"9","author":"Heald","year":"2020","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B5","unstructured":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American heart association\n          \n          \n            \n              Joseph\n              JJ\n            \n            \n              Deedwania\n              P\n            \n            \n              Acharya\n              T\n            \n          \n          \n          2022"},{"key":"B6","volume-title":"Idf Diabetes Atlas","author":"Magliano","year":"2021"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1239","article-title":"Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management","volume":"27","author":"Spallone","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06242-0","article-title":"Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management","volume":"67","author":"Eleftheriadou","year":"2024","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002480","article-title":"Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis","volume":"9","author":"Chowdhury","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.034626","article-title":"Sex differences in the association between cardiovascular autonomic neuropathy and mortality in patients with type 2 diabetes: the ACCORD study","volume":"14","author":"Zhou","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-S011","article-title":"8. Pharmacologic approaches to glycemic treatment","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5152\/AnatolJCardiol.2022.1934","article-title":"Dapagliflozin improves cardiac autonomic function measures in type 2 diabetic patients with cardiac autonomic neuropathy","volume":"26","author":"Balcioglu","year":"2022","journal-title":"Anatol J Cardiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155243","article-title":"SGLT2-inhibitors reduce the dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study","volume":"137","author":"Sardu","year":"2022","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.042375","article-title":"Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART CardioLink-6 randomized clinical trial","volume":"140","author":"Verma","year":"2019","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2020.100039","article-title":"Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 holter analysis","volume":"7","author":"Garg","year":"2020","journal-title":"Metab Open"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-022-01732-9","article-title":"Evaluating the use of novel atherogenicity indices and insulin resistance surrogate markers in predicting the risk of coronary artery disease: a case-control investigation with comparison to traditional biomarkers","volume":"21","author":"Mahdavi-Roshan","year":"2022","journal-title":"Lipids Health Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12974-021-02090-6","article-title":"The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke","volume":"18","author":"Gong","year":"2021","journal-title":"J Neuroinflamm"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179553","article-title":"Investigation of the associations of novel inflammatory biomarkers\u2014systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)\u2014with the severity of coronary artery disease and acute coronary syndrome occurrence","volume":"23","author":"Dziedzic","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/eurjpc\/zwaf081","article-title":"Advanced prediction of heart failure risk in elderly diabetic and hypertensive patients using nine machine learning models and novel composite indices: insights from NHANES 2003-2016","volume":"33","author":"Bai","year":"2026","journal-title":"Eur J Prev Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12933-022-01483-y","article-title":"The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study","volume":"21","author":"Park","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2024.09.007","article-title":"Serum glycosylated hemoglobin and prostate cancer risk: Results from a systematic review and dose-response meta-analysis","volume":"43","author":"Li","year":"2025","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"B27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.diabres.2011.03.012","article-title":"Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus","volume":"93","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"B28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12933-026-03108-0","article-title":"Prognostic stratification with composite insulin resistance\u2013inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses","volume":"25","author":"Ye","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40729-021-00360-9","article-title":"Glycemic fluctuation exacerbates inflammation and bone loss and alters microbiota profile around implants in diabetic mice with experimental peri-implantitis","volume":"7","author":"Li","year":"2021","journal-title":"Int J Implant Dent"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202210-1988LE","article-title":"Tight glycemic control, inflammation, and the ICU: evidence for heterogeneous treatment effects in two randomized controlled trials","volume":"207","author":"Zinter","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202409-1719OC","article-title":"Biologic mechanisms underlying the heterogeneous response to tight glycemic control among differentially inflamed patients in the HALF-PINT trial","volume":"211","author":"Zinter","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612348","article-title":"Tight glycemic control in critically ill children","volume":"376","author":"Agus","year":"2017","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab200","article-title":"Genetic predisposition to type 2 diabetes and insulin levels is positively associated with serum urate levels","volume":"106","author":"Zhu","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13862","article-title":"Blood glucose fluctuations detected by continuous glucose monitoring system in gout patients with normal glucose tolerance and the effect of urate-lowering therapy","volume":"23","author":"Mu","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/6830671","article-title":"Direct and indirect effects of serum uric acid on blood sugar levels in patients with prediabetes: a mediation analysis","volume":"2017","author":"Anothaisintawee","year":"2017","journal-title":"J Diabetes Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.33314\/jnhrc.v21i1.4781","article-title":"Correlation of serum uric acid and lipid profile in patients with type 2 diabetes mellitus","volume":"21","author":"Malla","year":"2023","journal-title":"J Nepal Health Res Counc"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036787","article-title":"Inflammatory markers and measures of cardiovascular autonomic neuropathy in type 1 diabetes","volume":"14","author":"Ang","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239005","article-title":"Cardiac autonomic neuropathy: a progressive consequence of chronic low-grade inflammation in type 2 diabetes and related metabolic disorders","volume":"21","author":"Bakkar","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B39","unstructured":"Neutrophil-to-lymphocyte ratio as a marker for cardiac autonomic neuropathy in Egyptian patients with type 2 diabetes: A cross-sectional study\n          \n          \n            \n              Assaad-Khalil\n              SH\n            \n            \n              Abdel Aaty\n              T\n            \n            \n              El Feky\n              M\n            \n          \n          \n          2024"},{"key":"B40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/heartjnl-2015-309181","article-title":"Inflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes","volume":"103","author":"Herder","year":"2017","journal-title":"Heart"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1901683\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:47:36Z","timestamp":1785905256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1901683\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":40,"alternative-id":["10.3389\/fendo.2026.1901683"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1901683","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"1901683"}}